PPAR Research

Editorial Board

Academic Editors

  • Rosa Amoroso , Department of Pharmacy, University of Chieti, Italy
  • Rozalyn M. Anderson, University of Wisconsin-Madison, USA
  • Marcin Baranowski , Medical University of Bialystok, Poland
  • Antonio Brunetti , Universita degli studi Magna Graecia di Catanzaro, Italy
  • Sharon Cresci , Washington University, USA
  • Paul D. Drew , University of Arkansas, USA
  • Brian N. Finck, Washington University, USA
  • Pascal Froment , L'institut de la Recherche Agronomique, France
  • Constantinos Giaginis, Assistant Professor Human Physiology Department of Food Science and Nutrition, University of the Aegean, Mitropoliti Ioakeim 2, 81400 Myrina, Limnos, Greece
  • Geoffrey Girnun , University of Maryland School of Medicine, USA
  • Tom Hsun-Wei Huang, University of Sydney, Australia
  • Ravinder K. Kaundal, Icahn School of medicine at Mount Sinai, USA
  • Markus P. Kummer , University of Bonn, Germany
  • Christopher Lau, U.S. Environmental Protection Agency, USA
  • Stéphane Mandard , Université de Bourgogne, France
  • Elisabetta Mueller, New York University, USA
  • Marcelo H. Napimoga , São Leopoldo Mandic Institute and Research Center, Brazil
  • Richard P. Phipps , University of Rochester, USA
  • Henrike Sell, German Diabetes-Center, Germany
  • Xu Shen , Chinese Academy of Sciences, China
  • Nguan Soon Tan , Nanyang Technological University, Singapore
  • John P. Vanden Heuvel , The Pennsylvania State University, USA
  • Raghu Vemuganti, University of Wisconsin, USA
  • Nanping Wang , Peking University, China
  • Qinglin Yang , University of Alabama at Birmingham, USA
  • Tianxin Yang, University of Utah, USA
    PPAR Research
     Journal metrics
    Acceptance rate44%
    Submission to final decision48 days
    Acceptance to publication38 days
    Impact Factor2.953

    We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.